Sign in
Taking people in South KoreaNo phase

Looking back at results after transcatheter aortic valve replacement for aortic valve stenosis

Reviews medical records of adults with aortic valve stenosis who had transcatheter valve replacement.

Key facts

Who runs it
Eunpyeong St. Mary's Hospital
Where
Seoul, South KoreaSee the site
Trial code
Registry title
CHATEAU Registry: Clinical Outcomes After Transcatheter Aortic Valve Replacement
Status
Recruiting
People taking part
4,000 people, planned
Started
1 Jan 2021
Expected to end
31 Dec 2027
Type of study
Observational
Treatments tested
  • Transcatheter Aortic Valve Replacement
Record updated
17 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who had a heart valve procedure called TAVR (transcatheter aortic valve replacement) for severe aortic valve disease. It only uses information already in their medical records.

Age
18 years and older
Sex
All sexes
Disease stage
Severe disease of the person's own (native) aortic valve.
Earlier treatment
People must have had TAVR at a participating centre between January 1, 2021 and December 31, 2025.

Main reasons for not taking part

  • Not enough clinical or procedure information in the records to judge the outcomes

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Adults (≥18 years of age)
  • Patients who underwent transcatheter aortic valve replacement (TAVR) for severe native aortic valve disease at participating centers
  • TAVR performed between January 1, 2021 and December 31, 2025
  • Availability of baseline procedural and follow-up clinical data in the institutional registry or medical records

Who cannot take part

  • Patients with insufficient clinical or procedural data for outcome assessment

Where in South Korea

  • The Catholic University of Korea, Eunpyeong St. Mary's HospitalSeoul, South KoreaContact: Osung Kwon, MD, PhDTaking people

About the trial

What the trial wants to find out

This study is a multicenter, retrospective registry study using the CHATEAU Registry. The study will evaluate patients who underwent transcatheter aortic valve replacement between January 2021 and December 2025. The purpose of the study is to assess clinical outcomes and valve performance after TAVR in real-world practice, with a focus on procedural strategies, valve-related factors, and long-term outcomes. Patient clinical information, imaging findings, procedural data, echocardiographic results, and follow-up outcomes will be collected from existing medical records. No additional intervention, treatment, or study-specific visit will be performed.

The group in the trial

  • CHATEAU Registry Cohort

    Consecutive adult patients with severe aortic valve disease who underwent transcatheter aortic valve replacement (TAVR) between January 1, 2021 and December 31, 2025 at participating centers in the CHATEAU Registry. Clinical, imaging, procedural, and follow-up data are collected retrospectively from routine clinical practice.

    Treatment: Transcatheter Aortic Valve Replacement

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: The Collaborative Hexagon-Asian Transcatheter Aortic Valve Replacement Union (CHATEAU) Registry
Plain-language title
Looking back at results after transcatheter aortic valve replacement for aortic valve stenosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
17 July 2026